Anti-programmed cell death-1 therapy in nonmelanoma skin cancer

被引：70
|
作者：
Winkler, J. K. [1 ,2 ]
Schneiderbauer, R. [1 ,2 ]
Bender, C. [1 ,2 ]
Sedlaczek, O. [2 ,3 ]
Froehling, S. [4 ,6 ,7 ]
Penzel, R. [5 ]
Enk, A. [1 ,2 ]
Hassel, J. C. [1 ,2 ]
机构：
[1] Univ Heidelberg Hosp, Dept Dermatol, Heidelberg, Germany
[2] Univ Heidelberg Hosp, Natl Ctr Tumor Dis NCT, Heidelberg, Germany
[3] Univ Heidelberg Hosp, Dept Diagnost Radiol, German Canc Res Ctr DKFZ, Heidelberg, Germany
[4] Univ Heidelberg Hosp, Sect Personalized Oncol, Heidelberg, Germany
[5] Univ Heidelberg Hosp, Dept Pathol, Heidelberg, Germany
[6] Natl Ctr Tumor Dis NCT, Heidelberg, Germany
[7] German Canc Res Ctr, Dept Translat Oncol, Heidelberg, Germany
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2017年 / 176卷 / 02期
关键词：
IMMUNOTHERAPY; VISMODEGIB;
D O I：
10.1111/bjd.14664
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：498 / 502
页数：5
相关论文
共 50 条
  • [1] Anti-programmed death-1 and anti-programmed death-ligand 1 antibodies in cancer therapy
    Hamid, Omid
    Carvajal, Richard D.
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (06) : 847 - 861
  • [2] The path forward for anti-programmed cell death-1 therapy in gliomas
    Majd, Nazanin
    Kamiya-Matsuoka, Carlos
    de Groot, John
    [J]. CURRENT OPINION IN NEUROLOGY, 2019, 32 (06) : 864 - 871
  • [3] Adrenal Insufficiency Related to Anti-Programmed Death-1 Therapy
    Ariyasu, Ryo
    Horiike, Atsushi
    Yoshizawa, Takahiro
    Dotsu, Yosuke
    Koyama, Junji
    Saiki, Masafumi
    Sonoda, Tomoaki
    Nishikawa, Shingo
    Kitazono, Satoru
    Yanagitani, Noriko
    Nishio, Makoto
    [J]. ANTICANCER RESEARCH, 2017, 37 (08) : 4229 - 4232
  • [4] Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy
    Naidoo, Jarushka
    Wang, Xuan
    Woo, Kaitlin M.
    Iyriboz, Tunc
    Halpenny, Darragh
    Cunningham, Jane
    Chaft, Jamie E.
    Segal, Neil H.
    Callahan, Margaret K.
    Lesokhin, Alexander M.
    Rosenberg, Jonathan
    Voss, Martin H.
    Rudin, Charles M.
    Rizvi, Hira
    Hou, Xue
    Rodriguez, Katherine
    Albano, Melanie
    Gordon, Ruth-Ann
    Leduc, Charles
    Rekhtman, Natasha
    Harris, Bianca
    Menzies, Alexander M.
    Guminski, Alexander D.
    Carlino, Matteo S.
    Kong, Benjamin Y.
    Wolchok, Jedd D.
    Postow, Michael A.
    Long, Georgina V.
    Hellmann, Matthew D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07) : 709 - +
  • [5] Clinical Perspectives to Overcome Acquired Resistance to Anti-Programmed Death-1 and Anti-Programmed Death Ligand-1 Therapy in Non-Small Cell Lung Cancer
    Lee, Yong Jun
    Lee, Jii Bum
    Ha, Sang-Jun
    Kim, Hye Ryun
    [J]. MOLECULES AND CELLS, 2021, 44 (05) : 363 - 373
  • [6] Pulmonary Infiltrates in Patients Treated with Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy
    Okada, A.
    Ota, K.
    Horimoto, K.
    Ibaraki, T.
    Murakami, S.
    Takenaka, H.
    Choh, S.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S1079 - S1080
  • [7] Myocarditis in patients treated with anti-programmed death-1/programmed death ligand 1 therapy.
    Wang, Hanping
    Guo, Xiaoxiao
    Tian, Ran
    Si, Xiaoyan
    Zhang, Xiaotong
    Wang, Jiangshan
    Zhao, Haitao
    Zhang, Li
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [8] Fulminant type1 diabetes mellitus with anti-programmed cell death-1 therapy
    Okamoto, Masahide
    Okamoto, Mitsuhiro
    Gotoh, Koro
    Masaki, Takayuki
    Ozeki, Yoshinori
    Ando, Hisae
    Anai, Manabu
    Sato, Asami
    Yoshida, Yuichi
    Ueda, So
    Kakuma, Tetsuya
    Shibata, Hirotaka
    [J]. JOURNAL OF DIABETES INVESTIGATION, 2016, 7 (06) : 915 - 918
  • [9] Autoimmune diabetes and anti-programmed cell death-1 (anti-PD-1) cancer immunotherapy
    Daltry, S.
    Bujanova, J.
    Cranston, I.
    [J]. DIABETIC MEDICINE, 2017, 34 : 102 - 102
  • [10] Sick sinus syndrome associated with anti-programmed cell death-1
    Hsu, Chien-Yi
    Su, Yu-Wen
    Chen, San-Chi
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
12345